Established over a decade ago, Virchow Healthcare Pvt. Ltd. (VHPL) came into existence in the year 2008 with a vision to achieve a reputation of providing the highest standards of biological and pharmaceutical formulations with a focus on best customer centric service.
After all these years we are happy that we have not wavered from our dream. We can confidently state that we are well on the path of achieving what we set out that many years ago.
The journey has been fulfilling, and with an excellent team on the helm we have taken long strides to create a trusted presence in over 50 countries across the globe. We continuously strive to meet the strictest regulatory standards whilst offering an array of outstanding quality products at competitive pricing for affordable healthcare.
We hail from a strong ethical and responsible business family, the Virchow Group of Companies.
Founded over 30 years ago, the Virchow Group now has a global footprint in over 50 countries supporting about 5,000 employees with an annual turnover of over $1 billion. The Virchow Group has a diversified business portfolio ranging from biotechnologicals, pharmaceuticals, medical devices, and APIs.
The group is the largest producer of Sulfamethoxazole, Trimethoprim, Ranitidine hydrochloride in the world.
It is also one the largest producers of Cephalosporins and Tramadol APIs in India.
When our obsession of an ideal future possibility is combined with the infallible strength and expertise of our group, the result is a bold dream of helping the fellow man, of banishing mediocrity, and of strengthening our strengths and weakening our weaknesses.
This is who we wish to be.